PD-1 and TIGIT play a significant role in the immunosuppressive response of T...
Results from the PEARLS/KEYNOTE-091 study, a triple-blind phase 3 trial, have...
The CheckMate 816 study has demonstrated that neoadjuvant nivolumab +...
Individuals diagnosed with oligometastatic NSCLC can benefit from local...
Divya Natesan from the University of Pittsburgh sought to examine the frequency...
The plenary session at ASCO saw Prof Roy S. Herbst of the Yale Cancer Center...
The possibility of performing surgical resection for non-small-cell lung cancer...
The CheckMate 9LA study has already demonstrated the significant benefit of...
Prof. Christophe Dooms from UZ Gasthuisberg in Leuven discussed several...
Dr Kristof Cuppens shares his insights on key presentations of ASCO 2023. Dr....